Brought to you by 
Biomet acquires Interpore for $297.4mm in cash
13 Jul 2004
Executive Summary
Orthopedic device company Biomet is acquiring Interpore International (dba Interpore Cross International; develops, manufactures, and sells spinal surgery products) for about $297.4mm. Biomet will pay $14.50 per share (a 29% premium over market average) in cash, or 4.4 times Interpore's 2003 sales revenue, for all of the company's approximately 20.5mm shares outstanding, fully diluted.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com